Control of risk factors for nephropathy among Nigerian outpatients with Type 2 diabetes mellitus

作者: Rimamde D Andeyaba , Tom D Thacher , Madaki JK Aboi , Emmanuel I Agaba

DOI:

关键词: Internal medicineDiabetes mellitusType 2 Diabetes MellitusBlood pressureMedicineDiabetic nephropathySurgeryNephropathyMetforminProteinuriaKidney disease

摘要: Background and Objectives : To determine the proportion of type 2 diabetic  outpatients with adequate control risk factors for nephropathy in a Nigerian teaching hospital. Methods Between April July 2005, 160 diabetic were  assessed average fasting blood glucose pressure over 3 visits, current use ACE inhibitors. All patients were 30 years age had been followed up at least one year 6 prior clinic visits. Results We studied 58 male 102 female subjects mean (±SD) 54±10 years. The majority (54.7%) diabetes between 1 5 years, 95% on antidiabetic drugs, most commonly both sulphonylurea metformin (64.5%). 114 (71.2%) being treated hypertension. (FBS) was 7.6±2.9mmol/L, 73 (45.6%) good glycaemic control  (mean FBS≤ 5.6mmol/L). A total 51 (31.9%) (<140/90mmHg non-hypertensives <130/80mmHg hypertensives), currently receiving Only five (3.1%) combination control, received Conversely, 23 (14.4%) poor not Duration (p<0.01), elevated creatinine systolic blood  (p<0.01) independently associated proteinuria. Conclusion Despite availability measures to prevent progression nephropathy, poor. Physicians Nigeria must work together improve their management nephropathy. Key words Diabetes mellitus, chronic kidney disease, renoprotection

参考文章(23)
Sharon H Saydah, Judith Fradkin, Catherine C Cowie, Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes JAMA. ,vol. 291, pp. 335- 342 ,(2004) , 10.1001/JAMA.291.3.335
A. M. Bernard, L. Anderson, C. B. Cook, L. S. Phillips, What do internal medicine residents need to enhance their diabetes care Diabetes Care. ,vol. 22, pp. 661- 666 ,(1999) , 10.2337/DIACARE.22.5.661
for the RENAAL Study Investigators* Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Parving HH, Remuzzi G, Snapinn S, Zhang X, Shahinfar S, None, EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY The New England Journal of Medicine. ,vol. 345, pp. 861- 869 ,(2001) , 10.1056/NEJMOA011161
Hans-Henrik Parving, Initiation and Progression of Diabetic Nephropathy The New England Journal of Medicine. ,vol. 335, pp. 1682- 1683 ,(1996) , 10.1056/NEJM199611283352212
Reginald P Sequeira, Khalid A Jassim Al Khaja, Awatif HH Damanhori, None, Evaluating the treatment of hypertension in diabetes mellitus: a need for better control? Journal of Evaluation in Clinical Practice. ,vol. 10, pp. 107- 116 ,(2004) , 10.1111/J.1365-2753.2003.00404.X
Hugh Alberti, Nessiba Boudriga, Mounira Nabli, Factors affecting the quality of diabetes care in primary health care centres in Tunis Diabetes Research and Clinical Practice. ,vol. 68, pp. 237- 243 ,(2005) , 10.1016/J.DIABRES.2004.09.016
David M. Nathan, Initial Management of Glycemia in Type 2 Diabetes Mellitus New England Journal of Medicine. ,vol. 347, pp. 1342- 1349 ,(2002) , 10.1056/NEJMCP021106